Overview
Vrsp S.A. is headquartered at Al. IX Wieków Kielc 6/4, 25-516 Kielce, Poland. The company is registered with the District Court in Kielce, 10th Commercial Division of the National Court Register, under KRS number 0000592349; its tax ID is 657-29-20-905, statistical number is 363159140, and its fully paid-up share capital amounts to PLN 133,000.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2015-11-27. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
18 notices recorded in the Court and Commercial Gazette (MSiG).
| Publication date | Event | |
|---|---|---|
| Jul 23, 2026 | Shareholders' meeting convened | |
| Jun 18, 2026 | Shareholders' meeting convened | |
| May 15, 2026 | Shareholders' meeting convened | |
| Jul 2, 2024 | Shareholders' meeting convened | |
| May 7, 2024 | Shareholders' meeting convened |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Nov 27, 2019 | Aid for research and development projects: industrial research | $1.7M$1,708,779 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Nov 27, 2019 | Aid for research and development projects: experimental development | $767.6K$767,631 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Nov 27, 2019 | Aid for consultancy services for small and medium-sized enterprises | $107.4K$107,427 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2019-11-01 | Stworzenie nowej generacji protezy głosowej dla osób po całkowitej laryngektomii | $2.6M$2,582,275 | Program Operacyjny Inteligentny Rozwój |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
The submission of declarations of will on behalf of the company requires the joint action of two members of the management board, and in the case of a one-person management board, the President of the Management Board acts independently.
Supervisory board
Beneficial owners
| Person | Rights | |
|---|---|---|
Sławomir Okła (58)  | Shareholder of a joint-stock company, 51.88% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Milton EssexS.A. | $40,863.48 | miltonessex.eu | ||
| Hemolens Diagnosticssp. z o.o. | $37,964.68 | hemolens.com | ||
| Pragma System Globalsp. z o.o. | $34,880.66 | pragma.systems | ||
| Smart Labssp. z o.o. | $32,047.41 | smart-labs.pl | ||
| SUMIsp. z o.o. | $21,015.77 | sumi.com.pl | ||
| Ethernasp. z o.o. | $20,428.04 | etherna.pl | ||
| Medintechsp. z o.o. | $16,560.95 | medintech.pl | ||
| BIO 3d Solutionssp. z o.o. | $11,692.51 | bio3dsolutions.com | ||
| Selex Polskasp. z o.o. | $7,765.44 | selexpolska.com | ||
| Therapiqsp. z o.o. | $7,482.34 | therapiq.eu |
Change history
| Date | Event | |
|---|---|---|
| 2020-10-02 | Share capital change (111,000.00 PLN → 133,000.00 PLN) | |
| 2020-03-30 | Share capital change (100,000.00 PLN → 111,000.00 PLN) | |
| 2015-12-16 | Entered in the register |
FAQ
Last updated: 2026-07-16